SCHEMBL7669452

SCHEMBL7669452

CCOC(=O)c1cc(C#N)cc2cc(C#N)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPK1 P28482 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
KDM4E B2RXH2 7/20 0.46
HSD17B10 Q99714 2/20 0.46
ALDH1A1 P00352 5/20 0.44
GAA P10253 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
GLA P06280 1/20 0.44
ATM Q13315 1/20 0.44
ELANE P08246 2/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 2/20 0.43
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
MEN1 O00255 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
CDC25B P30305 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7671281 0.91 CA12 (0.51) TSHRSMN1; SMN2MAPK1NPSR1KDM4E
SCHEMBL7671086 0.88 MAOB (0.53) TSHRSMN1; SMN2MAPK1NPSR1KDM4E
SCHEMBL6883767 0.83 TSHR (0.55) TSHRSMN1; SMN2MAPK1NPSR1KDM4E
SCHEMBL7667798 0.81 HSD11B1 (0.40) TSHRSMN1; SMN2MAPK1NPSR1KDM4E
SCHEMBL20944310 0.79 TSHR (0.46) TSHRSMN1; SMN2MAPK1NPSR1KDM4E
SCHEMBL22852763 0.79 TSHR (0.46) TSHRSMN1; SMN2MAPK1NPSR1KDM4E
SCHEMBL15639611 0.79 ALDH1A1 (0.55) TSHRSMN1; SMN2MAPK1NPSR1KDM4E
SCHEMBL30294840 0.79 TSHR (0.46) TSHRSMN1; SMN2MAPK1NPSR1KDM4E
SCHEMBL27944765 0.79 CYP4F2 (0.58) TSHRSMN1; SMN2MAPK1NPSR1KDM4E
SCHEMBL286232 0.79 CA12 (0.49) TSHRSMN1; SMN2MAPK1NPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365602-B1 FOR THERAPY OF DEPRESSION, ANXIETY, ASTHMA, PAIN, INFLAMMATION, URINARY INCONTINENCE AND OTHER DISEASE CONDITIONS ASTRA ZENECA AB (SE) 2002-04-02 US disclosed
CN-1309638-A N-substituted naphthamides as neurokinin receptor antagonists ASTRAZENECA AB (SE) 2001-08-22 CN disclosed
EP-1097137-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-05-09 EP disclosed
WO-2000002859-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed